Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Wisconsin Rapids › NPI 1679775415
Lab

Aspirus Riverview Hospital & Clinics, INC.

Aspirus Riverview Hospital & Clinics, INC. was paid $385K by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 80061, Lipid panel — 17% of everything it billed.

33Billing provider infoASPIRUS RIVERVIEW HOSPITAL & CLINICS, INC.
WISCONSIN RAPIDS, WI 54494
33aNPI1679775415assigned 06/04/2007
28Total paid$385K
24GClaims32,426
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Wisconsin

Rank by total paid#29 of 75
Median peer was paid$106K
This provider vs. median3.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,437$31K
20193,458$32K
20204,975$96K
20218,107$72K
20225,739$75K
20234,716$43K
2024incomplete3,994$36K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80061 Lipid panel 17% 6,368 5,871 $67K
84443 Thyroid stimulating hormone (TSH) 17% 5,101 4,637 $64K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 15% 745 652 $59K
80053 Comprehensive metabolic panel 7.2% 3,538 3,022 $28K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 6.5% 779 709 $25K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 6.1% 1,182 1,065 $24K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.8% 3,458 2,877 $18K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 4.3% 125 122 $17K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3.2% 265 253 $12K
84439 2.6% 1,437 1,312 $10K
82728 1.9% 744 688 $7K
80050 General health panel 1.7% 441 178 $7K
28 more codes
80306 1.7% 458 $6K
85027 1.6% 1,169 $6K
83036 Hemoglobin; glycosylated (A1C) 1.5% 778 $6K
80048 Basic metabolic panel (calcium, ionized) 1.4% 805 $5K
86140 1.1% 1,021 $4K
83735 <1% 560 $3K
80081 <1% 155 $2K
81001 <1% 967 $2K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 18 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 43 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 43 $2K
86803 <1% 86 $1K
85007 <1% 301 $932.53
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 74 $694.50
87653 <1% 13 $559.83
84153 <1% 31 $475.01
86850 <1% 158 $459.29
87210 <1% 98 $437.33
84702 <1% 36 $336.97
85610 <1% 78 $246.52
87086 Culture, bacterial; quantitative colony count, urine <1% 34 $225.33
87400 <1% 12 $194.58
86900 <1% 73 $148.75
86901 <1% 73 $142.77
85652 <1% 51 $104.49
87070 <1% 13 $95.25
82950 <1% 12 $42.16
36415 Collection of venous blood by venipuncture <1% 1,083 $39.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialYANG, JERRY (SVP & CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under YANG, JERRY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.